Daniel A Vaena

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Metastatic Renal Cell Carcinoma

Radical Prostatectomy

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta Kumar Pal, Michael R Pins, Jill M Kolesar, Archana M Agarwal, Rahul A Parikh, Daniel A Vaena, Christopher W Ryan, Mehmood Hashmi, Brian A Costello, David Cella, Janice P Dutcher, Robert S DiPaola, Naomi B Haas, Lynne I Wagner, Michael A Carducci
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (17) (2024)
Archana M Agarwal, Catherine M Tangen, Maha H A Hussain, Shilpa Gupta, Melissa Plets, Primo N Lara, Andrea L Harzstark, Przemyslaw W Twardowski, Channing J Paller, Dylan M Zylla, Matthew R Zibelman, Ellis G Levine, Bruce J Roth, Amir Goldkorn, Daniel A Vaena, Manish Kohli, Tony Crispino, Nicholas J Vogelzang, Ian M Thompson, David I Quinn
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (28) (2022)